EUVIMEDEUVIMED entdecken
Crossref

A Dendritic Cell‐Nanogel Conjugate for Tumor‐Draining Lymph Node‐Specific PD‐L1 Blockade

Wenzhe Yi, Xindi Qian, Dan Yan, Wenlu Yan, Shuangshuang Hu, Yaping Li iD, Dangge Wang

Advanced Materials · 2025-10 · 37 (39)

DOI: 10.1002/adma.202504733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 07.07.2025. Verfasst von Wenzhe Yi und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203,…. Hauptthemen laut MEDLINE: Dendritic Cells, Lymph Nodes, B7-H1 Antigen, Immune Checkpoint Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Strategic Priority Research Program of the Chinese Academy of Grant, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted blockade of immune checkpoints within tumor‐draining lymph nodes (TDLNs) represents a promising strategy to potentiate immune checkpoint blockade (ICB) therapy. However, the limited delivery of checkpoint inhibitors to TDLNs and inadequate T cell priming persist as major challenges. In this study, an innovative dendritic cell (DC)‐based strategy is developed for the targeted delivery of ICB antibodies to TDLNs. The platform is fabricated by conjugating anti‐PD‐L1 antibody nanogels with DCs, which are further enhanced by pre‐treating DCs with tumor antigens. Subcutaneous administration enabled DCs to execute their intrinsic TDLN‐tropic migration, thus facilitating antibody delivery and release under reductive conditions. The antigen‐loaded DCs mobilized T cell immunity, while the anti‐PD‐L1 antibodies block PD‐L1 on dendritic cells and myeloid cells within TDLNs, thereby augmenting systemic antitumor immunity. This approach significantly suppresses breast cancer growth, leading to 83.3% of treated mice being tumor‐free. This study presents a novel strategy for TDLN‐targeted PD‐L1 blockade by harnessing the intrinsic TDLN tropism of DCs, unveiling new translational opportunities of combining DC‐based vaccination with ICB therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsLymph NodesB7-H1 AntigenImmune Checkpoint InhibitorsAnimalsMiceFemaleCell Line, TumorMice, Inbred C57BLHumansGels

Stichwörter der Autor:innen

anti‐PD‐L1 antibodydendritic cellsimmunotherapytumor‐derived lymph nodes

Substanzen

B7-H1 AntigenImmune Checkpoint InhibitorsGels

Autor:innen und Institutionen

  • State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • University of Chinese Academy of Sciences, Beijing, 100049, China.
  • School of Life Sciences, Jilin University, Changchun, 130012, China.
  • Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, 264000, China.
  • Precision Research Center for Refractory Diseases, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201620, China.

ORCID-Profile: Yaping Li

Förderung

  • Strategic Priority Research Program of the Chinese Academy of Grant
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Shandong Laboratory Program
  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Rising-Star Program
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Yi, W., Qian, X., Yan, D., Yan, W., Hu, S., Li, Y., & Wang, D. (2025). A Dendritic Cell‐Nanogel Conjugate for Tumor‐Draining Lymph Node‐Specific PD‐L1 Blockade. Advanced Materials, 37(39). https://doi.org/10.1002/adma.202504733

Vancouver

Yi W, Qian X, Yan D, Yan W, Hu S, Li Y, et al. A Dendritic Cell‐Nanogel Conjugate for Tumor‐Draining Lymph Node‐Specific PD‐L1 Blockade. Advanced Materials. 2025;37(39). doi:10.1002/adma.202504733

BibTeX
@article{Yi2025,
  author = {Yi, Wenzhe and Qian, Xindi and Yan, Dan and Yan, Wenlu and Hu, Shuangshuang and Li, Yaping and Wang, Dangge},
  title = {A Dendritic Cell‐Nanogel Conjugate for Tumor‐Draining Lymph Node‐Specific PD‐L1 Blockade},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {39},
  doi = {10.1002/adma.202504733}
}
Kostenlos starten →